Cancer research
Colorectal cancer is a leading cause of cancer-related deaths in the US, and regular screening can significantly improve survival rates. However, many individuals do not undergo screening due to various barriers, including fear, limited access, or challenges with test preparation. Blood-based screening tests offer a non-invasive and more convenient alternative
Cancer research
Research on colorectal cancer screening among Latino adults has revealed low rates of screening, but a new study suggests that using fecal immunochemical tests (FITs) and text-based reminders can improve these rates. The study, conducted by investigators at the Kaiser Permanente Center for Health Research, employed a user-centered approach to
Cancer research
Research conducted in a large integrated healthcare system in the United States has found no conclusive evidence of an association between oral antibiotic use in adulthood and risk of early-onset colorectal cancer (EOCRC). The study aimed to evaluate the link between prior antibiotic use and EOCRC, as the incidence of
Cancer research
Researchers have developed a tumor growth inhibition- overall survival (TGI-OS) model for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer using clinical trial data available through Vivli, a clinical trial data sharing platform. The TGI-OS model, a parametric model linking TGI metrics and baseline predictors
Cancer research
Researchers from Quaid-I-Azam University have made significant progress in understanding breast cancer, identifying key biomarkers, and developing novel therapeutic agents. The study, published in the Journal of Chemical Information and Modeling, employed network-based gene expression profiling to identify differentially expressed genes (DEGs) as potential biomarkers in breast cancer. The analysis
Cancer research
A recent study published in Ethnicity & Health has shed light on the alarming racial disparities in the treatment and mortality rates of prostate cancer patients. Researchers analyzed a cohort of 244,468 men aged 65 and older, diagnosed with prostate cancer between 2007 and 2015. The findings revealed significant
Cancer research
New research from Memorial Sloan Kettering Cancer Center (MSK) is investigating whether introducing new mutations could make immunotherapy more effective against some cancers, showing that people in their 90s who underwent lung cancer surgery had positive outcomes, and sharing lessons on the responsible governance of artificial intelligence in oncology. Previous
Cancer research
Research has identified a new potential treatment for lung cancer, with gene therapy showing promising results in targeting cancer cells while sparing healthy ones. According to a study published in the Advanced NanoBiomed Research journal, researchers have created a gene therapy delivery system using chemically functionalized nanoscale graphene oxide (GO)
Cancer research
A study published in the journal Thorax found a correlation between consuming high amounts of ultra-processed foods (UPFs) and an increased risk of lung cancer in adults. The research team, led by academics in China, tracked the health and food habits of over 100,000 US adults with an average
Cancer research
A Phase 2 clinical trial has been initiated by the Guangzhou Institute of Respiratory Disease to study the efficacy of nano-crystalline megestrol acetate in patients with anorexia-cachexia syndrome (CACS) in advanced lung cancer. The trial aims to enroll 116 participants from the USA and investigate whether the combination of first-line
Cancer research
Jiangsu Cancer Hospital has initiated a clinical trial to study the efficacy and safety of Apatolimab Tovolimab combined with regorafenib and paclitaxel as a second-line treatment for patients with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma who have failed immunotherapy combined with chemotherapy. The open-label, multicenter phase II clinical
Cancer research
Advanced-stage prostate cancer, known as metastatic hormone refractory prostate cancer (mHRPC), poses significant treatment challenges. The disease progresses despite anti-androgen treatments, resulting in cancer spreading to bones and lymph nodes. Symptoms include persistent bone pain, fatigue, weight loss, and urinary issues, which can significantly decrease patient quality of life. The
